Artificial intelligence in pharmacovigilance: toward real-time, explainable, and global drug-safety systems
{{output}}
The expanding volume and heterogeneity of post-marketing drug-safety data have exposed the limitations of conventional pharmacovigilance systems. Artificial intelligence (AI) offers scalable solutions for detecting adverse drug reactions by integrating electro... ...
